Back to STATE STREET CORP STATE STREET CORP

NMRANMRA
Showing 8 of 11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in NEUMORA THERAPEUTICS INC

Yes. State Street holds 1,582,119 shares of NMRA (Neumora Therapeutics), worth $2.7M, as of its Q2 2026 13F filing. It increased the position from 398,719 shares in Q1 2026. State Street has held NMRA since Q4 2023, across 11 quarterly 13F filings.

Current Value

$2.7M

Current Shares

1.6M

Total Value Change

-$21M

Total Shares Change

-208,588

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+296.8%
$2.7M0.0%$1.70
42
2026-Q1
Increased
398,719
+2.5%
$777,5020.0%$3.06
17
2025-Q4
Unchanged
388,919
0.0%
$696,1650.0%$1.77
0
2025-Q3
Increased
388,919
+10.7%
$707,8330.0%$1.76
19
2025-Q2
Decreased
351,245
-79.6%
$257,5680.0%$0.76
0
2025-Q1
Decreased
1.7M
-16.4%
$1.7M0.0%$1.03
0
2024-Q4
Increased
2.1M
+15.0%
$21.8M0.0%$11.06
33
2024-Q3
Increased
1.8M
+65.3%
$23.7M0.0%$12.92
42

Other major holders of NMRA: SOFTBANK GROUP CORP., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used